Evidence map›Paper›PMID 24443420›Full record

ReviewAdvanced healthcare materials2014

Role of extracellular matrix signaling cues in modulating cell fate commitment for cardiovascular tissue engineering.

Karina H Nakayama, Luqia Hou, Ngan F Huang

Abstract readReview
In one paragraph

Review in Advanced healthcare materials, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 44 papers.

0numbers the graph read from it
0cells of the map it votes in
44citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

44 citing papers in PubMed.

  1. Article
  2. Review
  3. Mechanobiological Dynamics-Inspired Mechanomodulatory Biomaterials.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Signaling, cancer cell plasticity, and intratumor heterogeneity.Cell communication and signaling : CCS · 2024
    Article
  10. Recent Advances in Scaffolds for Guided Bone Regeneration.Biomimetics (Basel, Switzerland) · 2024
    Review
  11. Review
  12. Review
  13. Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Extracellular Matrix in Aging Aorta.Frontiers in cell and developmental biology · 2022
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Karina H NakayamaDepartment of Cardiothoracic Surgery, Stanford University, 300 Pasteur Dr, Stanford, CA, 94305, USA; Cardiovascular Institute, Stanford University, 265 Campus Drive, G1120, MC-5454, Stanford, CA, 94305, USA; Veterans Affairs Palo Alto Health Care System, 3801 Miranda Avenue, Mail Code 153, Palo Alto, CA, 94304 60031l, 650-493-5000, USA.
Luqia Hou
Ngan F Huang

Funding

T32 Training Program in Mechanisms and Innovation in Vascular DiseaseT32HL098049 · NHLBI · STANFORD UNIVERSITY · PI Nicholas James Leeper, Philip S Tsao · 2010 to 2026
$6.3M
Matrix-mediated endothelial differentiation of induced pluripotent stem cellsR00HL098688 · NHLBI · PALO ALTO VETERANS INSTIT FOR RESEARCH · PI HUANG, NGAN F. · 2013 to 2016
$742k
NHLBI NIH HHS R00 HL098688NHLBI NIH HHS R00HL098688NHLBI NIH HHS T32 HL098049
6 · The paper itself

Abstract

It is generally agreed that engineered cardiovascular tissues require cellular interactions with the local milieu. Within the microenvironment, the extracellular matrix (ECM) is an important support structure that provides dynamic signaling cues in part through its chemical, physical, and mechanical properties. In response to ECM factors, cells activate biochemical and mechanotransduction pathways that modulate their survival, growth, migration, differentiation, and function. This Review describes the role of ECM chemical composition, spatial patterning, and mechanical stimulation in the specification of cardiovascular lineages, with a focus on stem cell differentiation, direct transdifferentiation, and endothelial-to-mesenchymal transition. The translational application of ECMs is discussed in the context of cardiovascular tissue engineering and regenerative medicine.

Indexed as

AnimalsCell DifferentiationCell LineageExtracellular MatrixHumansMechanotransduction, CellularMyocardiumMyocytes, CardiacRegenerative MedicineSignal TransductionTissue Engineeringcardiovascularcell fateextracellular matrixstem cellstissue engineering

Identifiers

PMID24443420
PMCPMC4031033

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.